Connect with us

Hi, what are you looking for?

Capital Business
Capital Business
Pharmaceutical giant GlaxoSmithKline employs 6,000 staff across its nine manufacturing plants in Britain/AFP-File

Enterprise

UK drugs giant GSK invests £275m despite Brexit

Pharmaceutical giant GlaxoSmithKline employs 6,000 staff across its nine manufacturing plants in Britain/AFP-File

Pharmaceutical giant GlaxoSmithKline employs 6,000 staff across its nine manufacturing plants in Britain/AFP-File

LONDON, United Kingdom, Jul 27 – Drugmaker GlaxoSmithKline on Wednesday revealed plans to invest £275 million into three of its British manufacturing sites, shrugging off Brexit worries.

The investment worth $361 million or 328 million euros will be ploughed into facilities in Barnard Castle in northeastern England, Ware in the southeast, and Montrose in Scotland, GSK said in a statement.

The move will “boost production and support delivery of its latest innovative respiratory and large molecule biological medicines”, it said, adding that the “vast majority” of products will be exported globally.

GSK, which already employs 6,000 staff across its nine manufacturing plants in Britain, also noted that the investment would provide new job opportunities.

“Today’s announcement reflects further investment to support our pharmaceutical pipeline and meet growing demand for our innovative portfolio of newly launched products,” said chief executive Andrew Witty, who had backed the unsuccessful ‘Remain’ campaign in Britain’s June 23 EU membership vote.

“It is testament to our skilled UK workforce and the country’s leading position in life sciences that we are making these investments in advanced manufacturing here,” added Witty.

“From their manufacture in the UK, many of these medicines will be sent to patients around the world.”

GSK said it regards Britain as an “attractive” location because of its skilled workforce, technological and scientific capabilities and infrastructure — and its “competitive” corporate tax system.

The new investment was unveiled ahead of publication of the company’s second-quarter results later on Wednesday.

Advertisement. Scroll to continue reading.
Click to comment
Advertisement

More on Capital Business

Executive Lifestyle

NAIROBI, Kenya, Mar 12 – The country’s super wealthy individuals are increasing their holding of bonds, gold and cash, a new report by Knight...

Ask Kirubi

NAIROBI, Kenya, Mar 9 – Businessman and industrialist Dr. Chris Kirubi has urged members of the public to exercise extreme caution when making any...

Ask Kirubi

NAIROBI, Kenya, Mar 24 – Businessman and industrialist Dr. Chris Kirubi is set to own half of Centum Investment Company PLC, following a go-ahead...

Headlines

NAIROBI, Kenya, Mar 18 – Commercial Banks have been ordered to provide relief to borrowers on their personal loans, with loans eligible from March...

Kenya

NAIROBI, Kenya, Jun17 – Kenya’s tea leaves manufacturer Kericho Gold, has been awarded the Superbrands Seal by Superbrands East Africa for their quality variety...

Coronavirus

NAIROBI, Kenya, Mar 22 – Airtel Kenya is offering free internet access for students in order to enable continued learning at home in the...

Coronavirus

NAIROBI, Kenya, Apr 13 – As the local telecommunications industry gears up to roll out 5G networks in the country, the Communications Authority of...

Ask Kirubi

It is without a doubt that the COVID-19 pandemic has caught the whole world by surprise. Although its full impact is yet to be...